The PEACE Within represents Janssen’s commitment to supporting people living with immune-mediated inflammatory diseases (IMIDs). We do this in many ways: by partnering with patient advocacy groups and working with doctors, scientists and institutions all around the world, and by staying motivated to achieve a world where IMIDs are a thing of the past.
Our commitment to the PEACE Within
When a person lives with an IMID, there is a battle being waged within their immune system which causes it to malfunction; we want to restore balance. Every member of our team is striving to bring the PEACE Within to people living with IMIDs.
Through our unceasing research, we continue to improve our understanding of the immune system, and to discover and develop better treatments. We will not rest until we achieve a world where immune-mediated inflammatory disease is a thing of the past. We are for the PEACE Within.
Read about our work in Immunology
Learn about what people living with IMIDs face and what Janssen is doing to help them overcome these obstacles: including research, partnerships and innovative support.
What are immune-mediated inflammatory diseases (IMIDs)?
There are up to 70 million people in Europe living with IMIDs such as Crohn’s disease, ulcerative colitis, psoriasis, psoriatic arthritis and rheumatoid arthritis.
These conditions all share a common link: they are debilitating, chronic, life-shortening and sometimes even fatal. Pain, fatigue and an inability to perform everyday tasks are the most apparent symptoms, and many people also suffer from severe comorbidities. These diseases can develop at any age, and have a significant impact on quality of life. , , , , 
“Our work aims to raise the bar to make periods of disease remission more durable and allow patients with these debilitating diseases to lead normal lives.”
Ludovic de Beaucoudrey, MD
Janssen Therapeutic Area Lead, Immunology, Europe, Middle East & Africa
My IBD Journey
Looking for practical tips on living with inflammatory bowel disease (IBD)? Head to the My IBD Journey page, where you will find a series of short animations providing helpful advice about living well with IBD. These animations have been developed in association with the European Federation of Crohn’s and Ulcerative Colitis Associations (EFCCA).MY IBD JOURNEY
If you want to learn more about psoriasis or psoriatic arthritis, check out Beyond Expectations, our online patient portal for people living with psoriatic disease or who are interested in learning more about the disease and treatment options.Beyond Expectations
 Cooper G, Bynum M and Somers E. Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of disease. J Autoimmune 2009;33:197–207
 Bacconnier L, Rincheval N, et al. Psychological distress over time in early rheumatoid arthritis: results from a longitudinal study in an early arthritis cohort. Rheumatology (Oxford) 2015;54:520–527.
 Pompili M, Innamorati M, et al. Suicide risk and psychiatric comorbidity in patients with psoriasis. J Int Med Res 2016;44(1 suppl):61–67.
 Amador-Patarroyo M, Rodriguez-Rodriguez A, et al. How does age at onset influence the outcome of autoimmune diseases? Autoimmune Dis 2012;2012:251730.
 Habibi F, Habibi M, et al. Quality of life in inflammatory bowel disease patients: A cross-sectional study. J Res Med Sci 2017;22:104.
 Becker H, Grigat D, et al. Living with inflammatory bowel disease: A Crohn's and Colitis Canada survey. Can J Gastroenterol Hepatol 2015;29(2):77–84.
 Griffiths C, van der Walt J, et al. The global state of psoriasis disease epidemiology: a workshop report. Br J Dermatol 2017;177(1):e4–e7.
 Cieza A, et al. Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet 2020; 396,(10267):P2006-2017
 Alatab S, et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet gastroenterology & hepatology 2020;5.1:17-30.
 Ogdie A, et al. The Epidemiology Psoriatic Arthritis. Rheum Dis Clin North Am 2015;41(4):545-568